Inhibition of Platelet Aggregation With Eptifibatide, Bivalirudin, and Heparin in Patients Undergoing Percutaneous Coronary Intervention Receiving Clopidogrel Pretreatment (The PharmacoDynamic Evaluation of Angiomax, Clopidogrel With Or Without INtegrilin

The present study assessed the magnitude of inhibition of platelet aggregation induced by adenosine diphosphate and thrombin receptor activating peptide achieved with unfractionated heparin, the direct thrombin inhibitor bivalirudin, and the glycoprotein IIb/IIIa inhibitor eptifibatide in patients who underwent percutaneous coronary intervention and and were treated with concomitant aspirin and clopidogrel.